What could cause an estimated glomerular filtration rate (eGFR) that drops to about 39 mL/min/1.73 m² and then rises to roughly 106 mL/min/1.73 m² after three months?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 3, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Acute Kidney Injury (AKI) with Complete Recovery

The most likely explanation for an eGFR dropping to 39 mL/min/1.73 m² and then rising to 106 mL/min/1.73 m² three months later is acute kidney injury (AKI) that completely resolved, returning kidney function to baseline or near-baseline levels.

Understanding the Clinical Scenario

This dramatic improvement in eGFR represents a >170% increase from the nadir, which is characteristic of reversible AKI rather than chronic kidney disease (CKD). The KDIGO AKI guidelines define AKI as an acute change in kidney function occurring within 48 hours to 7 days 1, 2. While the guidelines focus on short-term changes, the principle of reversibility extends to recovery periods of weeks to months.

Key Distinguishing Features

The pattern you describe has several important characteristics:

  • Magnitude of change: A rise from 39 to 106 mL/min/1.73 m² represents near-complete or complete recovery
  • Timeline: Three months is consistent with AKI recovery, particularly for severe cases
  • Final eGFR: 106 mL/min/1.73 m² suggests return to normal or near-normal baseline function

Most Common Causes of Reversible AKI

Pre-renal AKI (Most Common)

  • Volume depletion: Dehydration, hemorrhage, gastrointestinal losses
  • Hypotension: Sepsis, heart failure exacerbation, medications
  • Reduced effective circulating volume: Cirrhosis, nephrotic syndrome

Medication-Induced AKI

  • NSAIDs: Cause hemodynamic changes affecting glomerular filtration
  • ACE inhibitors/ARBs: Particularly with concurrent volume depletion
  • Diuretics: Excessive use leading to volume depletion
  • SGLT2 inhibitors: Can cause initial eGFR decline of 7-10% that typically recovers 3

Contrast-Induced AKI (CI-AKI)

The guidelines provide specific risk stratification for radiocontrast nephropathy 1. With baseline eGFR 20-40 mL/min/1.73 m², the risk is elevated, but recovery is typical when it occurs.

Acute Tubular Necrosis (ATN)

  • Ischemic: From prolonged hypotension or shock
  • Nephrotoxic: Aminoglycosides, amphotericin, cisplatin
  • Recovery typically occurs over 1-3 months as tubular cells regenerate

Obstruction

  • Urinary tract obstruction: Stones, prostatic hypertrophy, malignancy
  • Complete recovery expected if obstruction relieved promptly

Critical Pitfalls to Avoid

Laboratory Error or Measurement Issues

Before attributing this to true AKI recovery, verify:

  • Creatinine assay method: Different methods (Jaffe vs. enzymatic) can yield different results 2
  • Hydration status: Significant volume changes between measurements
  • Muscle mass changes: Acute illness with muscle wasting can lower creatinine independent of GFR
  • Laboratory error: Repeat measurement to confirm

Acute-on-Chronic Kidney Disease

If the patient had underlying CKD with baseline eGFR around 40-50 mL/min/1.73 m², an acute insult could have temporarily dropped it to 39, with recovery to their baseline (not 106). The final eGFR of 106 argues strongly against this scenario.

Glomerular Hyperfiltration

Research shows that eGFR can fluctuate significantly in certain conditions 4. However, hyperfiltration typically involves gradual changes over years, not acute drops followed by rapid recovery.

Diagnostic Approach

Immediately review:

  1. Medication history: Any nephrotoxic drugs, diuretics, ACE-I/ARBs, NSAIDs started before the low eGFR?
  2. Clinical context at time of eGFR 39: Hospitalization? Acute illness? Imaging with contrast? Surgery?
  3. Volume status: Evidence of dehydration, heart failure, or hypotension?
  4. Urinalysis from the acute period: Proteinuria, hematuria, casts would suggest intrinsic kidney disease
  5. Other labs: BUN:Cr ratio >20:1 suggests pre-renal; fractional excretion of sodium if available

If no clear cause identified:

  • Consider urinary tract imaging to exclude obstruction (though less likely given complete recovery)
  • Review for AKI risk factors per KDIGO staging 1: hypotension, heart failure, sepsis, nephrotoxic exposures

Prognostic Implications

The complete recovery to eGFR 106 is excellent prognostically. Research demonstrates that patients who recover kidney function after AKI have significantly better long-term outcomes 5. However, even with complete recovery, prior AKI increases risk for future CKD, so ongoing monitoring is warranted.

Follow-up Recommendations

  • Repeat eGFR in 3-6 months to confirm stability
  • Urinalysis to screen for proteinuria or hematuria
  • Avoid nephrotoxic exposures when possible
  • Optimize cardiovascular risk factors: Hypertension and cardiovascular disease predict rapid eGFR decline 6

Bottom Line

This pattern overwhelmingly suggests reversible AKI with complete recovery. The most common causes are pre-renal azotemia (volume depletion, hypotension) or medication-induced injury. The key is identifying the precipitating event through careful history review of the period when eGFR was 39. The excellent recovery to 106 mL/min/1.73 m² indicates the kidney injury was functional or acute tubular in nature rather than structural/chronic, and the prognosis is favorable with appropriate preventive measures going forward.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.